An Act authorizing pharmacists to provide opioid use disorder treatment
House: Accompanied a study order, see H5210
Email me when H 4014 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 4014. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill would make collaborative drug therapy for opioid use disorder performed by pharmacists a covered, reimbursable service. It applies to state employee insurance, Medicaid managed‑care plans, private health policies, hospital contracts and health‑maintenance contracts, and gives pharmacists the same participation rights as physicians and other non‑physician clinicians. The measure failed to pass.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 4014
3 free questions a day, no accountHearings
- The Joint Committee on Financial Services will hold a public hearing on the following health insurance matters.Joint Committee on Financial Services · Sep 17, 2025
History
- Accompanied a study order, see H5210
- Hearing scheduled for 09/17/2025 from 12:30 PM-04:30 PM in Gardner Auditorium
- Senate concurred
- Referred to the committee on Financial Services
Sponsors
- Carmine Lawrence Gentile · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 4014 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 4014 freeOr ask your AI assistant about H 4014 directly:
Add to Claude, ChatGPT or Cursor